BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sawicki E, Hillebrand MJ, Rosing H, Schellens JHM, Nuijen B, Beijnen JH. Validation of a liquid chromatographic method for the pharmaceutical quality control of products containing elacridar. J Pharm Anal 2016;6:268-75. [PMID: 29403992 DOI: 10.1016/j.jpha.2016.04.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Janga KY, Tatke A, Shukla S, Lamichhane SP, Avula B, Wang X, Jablonski MM, Khan IA, Majumdar S. Retina Compatible Interactions and Effective Modulation of Blood Ocular Barrier P-gp Activity by Third-Generation Inhibitors Improve the Ocular Penetration of Loperamide. J Pharm Sci 2018;107:2128-35. [PMID: 29678592 DOI: 10.1016/j.xphs.2018.04.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
2 Sawicki E, Schellens JH, Beijnen JH, Nuijen B. Pharmaceutical development of an amorphous solid dispersion formulation of elacridar hydrochloride for proof-of-concept clinical studies. Drug Dev Ind Pharm 2017;43:584-94. [PMID: 28010129 DOI: 10.1080/03639045.2016.1274901] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]